Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Evidence suggests that early‐onset gastric cancers are distinct from traditional gastric cancers; however, detailed genomic and morphologic characterization of these cancers has not been performed.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Genomic analysis was performed for 81 patients with gastric cancer who were 50 years old or younger; pathology slides were available for 53 of these patients, and they were re‐reviewed to perform a morphologic‐molecular correlation analysis. The results were compared with corresponding cBioPortal data and The Cancer Genome Atlas (TCGA) analysis, which represent traditional gastric cancers. The TP53 molecular signature was established to determine the pattern of somatic mutational damage. Variants of potential germline origin were also identified from next‐generation sequencing data.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>A higher rate of <i>CDH1</i> mutations (22.2% of early‐onset gastric cancers vs 11.4% of traditional gastric cancers; <i>P</i> = .0042) but a similar rate of <i>TP53</i> mutations (63% of early‐onset gastric cancers vs 56.6% of traditional gastric cancers; <i>P</i> = .2674) were seen in early‐onset cancers in comparison with traditional gastric cancers. The diffuse/mixed types correlated with the TCGA genomically stable type, and the remaining Lauren types correlated with the TCGA chromosomal instability type. Diffuse and indeterminate histologic types (overall survival, 26.25 months for the intestinal type, 20.5 months for the mixed type, 12.62 months for the diffuse type, and 9 months for the indeterminate type; <i>P</i> = .027) and the presence of a <i>CDH1</i> gene mutation (overall survival, 9 months for mutant <i>CDH1</i> and 22 months for wild‐type <i>CDH1</i>; <i>P</i> = .013) significantly correlated with worse survival. The <i>TP53</i> gene frequently showed transition mutations (65.5%) involving the CpG sites (49%). Variants of potential germline origin were seen in high‐penetrance genes (<i>CDH1</i> and <i>APC</i>) and moderate‐penetrance genes (<i>ATM</i>, <i>NBN</i>, and <i>MUTYH</i>) in 9.9% of cancers. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Early‐onset gastric cancer has distinct genomic alterations, such as <i>CDH1</i> mutations, but shares with traditional gastric cancers a high frequency of <i>TP53</i> mutations and the <i>TP53</i> mutagenic signature. Diffuse and indeterminate histologic types and the presence of a <i>CDH1</i> mutation are associated with worse overall survival. Endogenous factors leading to cytosine deamination and potential germline alterations in moderate‐penetrance cancer susceptibility genes may be implicated in the pathogenesis of these cancers. </p></section>

Whole-Exome Sequencing Reveals Molecular Characterization of Early-Onset and Peritoneal Metastasis in Gastric Cancers

Identification of Significant Biomarkers and Pathways Associated with Gastric Carcinogenesis by Whole Genome-Wide Expression Profiling Analysis

Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer

Integrated DNA and RNA sequencing to reveal early drivers of metastasis in gastric cancer.

Somatic mutations that affect early genetic progression and immune microenvironment in gastric carcinoma

Integrated DNA and RNA sequencing reveals early drivers involved in metastasis of gastric cancer

Clinical and Genetic Characteristics of Early and Advanced Gastric Cancer

Genomic alterations in gastric cancers discovered via whole-exome sequencing

Molecular Profiles and Metastasis Markers in Chinese Patients with Gastric Carcinoma

Oncogenic aberrations in primary gastric cancer tumors to predict metachronous peritoneal metastasis.

Somatic Alteration Characteristics of Early-Onset Gastric Cancer

Morphologic and molecular analysis of early‐onset gastric cancer

Whole-genome Sequencing Reveals Novel Tandem-Duplication Hotspots and a Prognostic Mutational Signature in Gastric Cancer

Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites

Genomic Alterations in Advanced Gastric Cancer Endoscopic Biopsy Samples Using Targeted Next-Generation Sequencing

Pathogenic Germline Mutations in Chinese Patients with Gastric Cancer Identified by Next-Generation Sequencing

Characterization and Validation of Somatic Mutation Spectrum to Reveal Heterogeneity in Gastric Cancer by Single Cell Sequencing

[Clinicopathological and Molecular Diagnostic Features of Early-Onset Gastric Cancer: a Study Based on Data from a Single-Center Dedicated Gastric Cancer Database].

Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing

A comparison analysis of the somatic mutations in early-onset gastric cancer and traditional gastric cancer

Identification of Key Genes and Signaling Pathways Associated with the Progression of Gastric Cancer